573 related articles for article (PubMed ID: 8197161)
1. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.
Bamford RN; Grant AJ; Burton JD; Peters C; Kurys G; Goldman CK; Brennan J; Roessler E; Waldmann TA
Proc Natl Acad Sci U S A; 1994 May; 91(11):4940-4. PubMed ID: 8197161
[TBL] [Abstract][Full Text] [Related]
2. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.
Burton JD; Bamford RN; Peters C; Grant AJ; Kurys G; Goldman CK; Brennan J; Roessler E; Waldmann TA
Proc Natl Acad Sci U S A; 1994 May; 91(11):4935-9. PubMed ID: 8197160
[TBL] [Abstract][Full Text] [Related]
3. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.
Grabstein KH; Eisenman J; Shanebeck K; Rauch C; Srinivasan S; Fung V; Beers C; Richardson J; Schoenborn MA; Ahdieh M
Science; 1994 May; 264(5161):965-8. PubMed ID: 8178155
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition of lymphokine-activated killing, proliferation, and cytokine secretion by humanized antibodies against the low- and intermediate-affinity interleukin-2 receptors. A novel model for activation of human peripheral blood mononuclear cells by interleukin 2.
Heaton KM; Grimm EA
Hum Immunol; 1995 Mar; 42(3):274-80. PubMed ID: 7759316
[TBL] [Abstract][Full Text] [Related]
5. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
[TBL] [Abstract][Full Text] [Related]
6. Regulation of CD3- lymphocyte function with an antibody against the IL-2 beta chain receptor: modulation of NK and LAK activity and production of IFN gamma.
Ortaldo JR; Frey J; Takeshita T; Sugamura K
Eur Cytokine Netw; 1990; 1(1):27-34. PubMed ID: 2151685
[TBL] [Abstract][Full Text] [Related]
7. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
Carson WE; Giri JG; Lindemann MJ; Linett ML; Ahdieh M; Paxton R; Anderson D; Eisenmann J; Grabstein K; Caligiuri MA
J Exp Med; 1994 Oct; 180(4):1395-403. PubMed ID: 7523571
[TBL] [Abstract][Full Text] [Related]
8. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
9. Lymphokine-activated killer cell activity of CD4-CD8- TCR alpha beta + thymocytes.
Arase H; Arase-Fukushi N; Good RA; Onoé K
J Immunol; 1993 Jul; 151(2):546-55. PubMed ID: 8335898
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-15 effectively potentiates the in vitro tumor-specific activity and proliferation of peripheral blood gammadeltaT cells isolated from glioblastoma patients.
Yamaguchi T; Suzuki Y; Katakura R; Ebina T; Yokoyama J; Fujimiya Y
Cancer Immunol Immunother; 1998 Oct; 47(2):97-103. PubMed ID: 9769118
[TBL] [Abstract][Full Text] [Related]
11. The IL-2 receptor beta subunit is absolutely required for mediating the IL-2-induced activation of NK activity and proliferative activity of human large granular lymphocytes.
Umehara H; Bloom ET
Immunology; 1990 May; 70(1):111-5. PubMed ID: 2354855
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
Naume B; Gately M; Espevik T
J Immunol; 1992 Apr; 148(8):2429-36. PubMed ID: 1373169
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells.
Nakarai T; Robertson MJ; Streuli M; Wu Z; Ciardelli TL; Smith KA; Ritz J
J Exp Med; 1994 Jul; 180(1):241-51. PubMed ID: 8006584
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Facco M; Trentin L; Sancetta R; Tassinari C; Perin A; Milani A; Pizzolo G; Rodeghiero F; Agostini C; Meazza R; Ferrini S; Semenzato G
Blood; 1997 Jan; 89(1):201-11. PubMed ID: 8978293
[TBL] [Abstract][Full Text] [Related]
15. Interleukin (IL)-2 and IL-3 induce distinct but overlapping responses in murine IL-3-dependent 32D cells transduced with human IL-2 receptor beta chain: involvement of tyrosine kinase(s) other than p56lck.
Otani H; Siegel JP; Erdos M; Gnarra JR; Toledano MB; Sharon M; Mostowski H; Feinberg MB; Pierce JH; Leonard WJ
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2789-93. PubMed ID: 1557384
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the ovine interleukin-2 receptor-alpha chain: differential induction on precultured alpha beta and gamma delta T cells.
Verhagen AM; Brandon MR; Nash AD
Immunology; 1993 Jul; 79(3):471-8. PubMed ID: 8406574
[TBL] [Abstract][Full Text] [Related]
17. Humanized Mik beta 1, a humanized antibody to the IL-2 receptor beta-chain that acts synergistically with humanized anti-TAC.
Hakimi J; Ha VC; Lin P; Campbell E; Gately MK; Tsudo M; Payne PW; Waldmann TA; Grant AJ; Tsien WH
J Immunol; 1993 Jul; 151(2):1075-85. PubMed ID: 8335891
[TBL] [Abstract][Full Text] [Related]
18. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptor.
Burdach S; Zessack N; Dilloo D; Shatsky M; Thompson D; Levitt L
J Clin Invest; 1991 Jun; 87(6):2114-21. PubMed ID: 1828253
[TBL] [Abstract][Full Text] [Related]
20. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
